Galectin Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $224k | 48k | 4.64 |
| 2025-03-31 | $20k | 16k | 1.22 |
| 2024-12-31 | $23k | 18k | 1.29 |
| 2024-09-30 | $48k | 17k | 2.75 |
| 2024-06-30 | $44k | 19k | 2.26 |
| 2021-03-31 | $67k | 31k | 2.18 |
| 2020-12-31 | $63k | 28k | 2.23 |
| 2020-09-30 | $68k | 25k | 2.67 |
| 2020-06-30 | $97k | 32k | 3.05 |
| 2020-03-31 | $60k | 31k | 1.95 |
| 2019-12-31 | $88k | 31k | 2.86 |
| 2019-09-30 | $100k | 27k | 3.66 |
| 2019-06-30 | $113k | 27k | 4.15 |
| 2015-03-31 | $59k | 18k | 3.32 |
| 2014-12-31 | $50k | 14k | 3.48 |
| 2014-09-30 | $70k | 14k | 5.03 |
| 2014-06-30 | $192k | 14k | 13.78 |